Whole-genome sequencing of antimicrobial-resistant pathogens is increasingly being used
for antimicrobial resistance (AMR) surveillance, particularly in high-income countries …

Throughout scientific literature, we can find evidence that antimicrobial resistance has
become a big problem in the recent years on a global scale. Public healthcare systems all …

Due to the increasing threat to public health and the economy, governments internationally
are interested in models to estimate the future clinical and economic burden of antimicrobial …

Antimicrobial resistance (AMR) is a major global health issue. Current measures for tackling
it comprise mainly the prudent use of drugs, the development of new drugs, and rapid …

BACKGROUND Many decisions in health care aim to maximise health, requiring
judgements about interventions that may have higher health effects but potentially incur …

Antimicrobial resistance is a serious challenge to the success and sustainability of our
healthcare systems. There has been increasing policy attention given to antimicrobial …

Evidence-based decision-making to combat antimicrobial resistance (AMR) mandates a well-
built community-based surveillance system for assessing resistance patterns among …

Antimicrobial resistance (AMR) is a complex issue of major global concern, and infectious
organisms are now becoming increasingly resistant to the array of existing antimicrobials …

Healthcare decision making, including regulatory and reimbursement decisions, is based on
uncertain assessments of clinical and economic value. This arises from the evidence …

BACKGROUND To limit the use of antimicrobials without disincentivising the development of
novel antimicrobials, there is interest in establishing innovative models that fund …